Study to determine safety and tolerability of oral lucerastat in adult subjects with Fabry disease
Enrolling By Invitation
18-99 years
All
Phase
3
1 participants needed
1 Location
Brief description of study
The purpose of this study is to study how a new investigational drug called lucerastat works in research subjects. Taking part in a research study is different from getting regular medical care. The aim of regular care is to improve your health. The aim of a research study is to collect and analyze information, which may help patients to get better care in the future.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: Fabry disease
-
Age: Between 18 Years - 99 Years
-
Gender: All
Updated on
01 Aug 2024.
Study ID: 849526
If you need assistance finding a non-cancer clinical research study or if you have any questions, please email psom-ocr@pobox.upenn.edu
For cancer trials contact EmergingMed: 1-855-216-0098 or PennCancerTrials@emergingmend.com
